Robin Coope's Biography

Robin Coope, Group Leader and CoDirector, British Columbia Cancer Agency Genome Sciences Centre

Robin Coope is the Instrumentation Group Leader at the BC Cancer Agency's Genome Sciences Centre and has been in the genomics field since 2000. In this position Dr. Coope is responsible for evaluating new instrumentation as well as designing de-novo solutions. He holds a BASc and MASc in Engineering Physics and a PhD in Physics from the University of British Columbia. At the GSC, Dr. Coope led several large scale automation efforts including mechanizing a large scale genomic mapping pipeline to characterize large scale rearrangements in follicular lymphoma genomes and more recently, leading the development of the first 96 channel size selection robot for NGS sample preparation. The latter has recently been licensed to a spinoff company, Coastal Genomics, who are commercializing it. As co-director of the Genome British Columbia Technology Development Platform, Dr. Coope has also been involved in several biomedical device development projects, including a novel implant for minimally invasive fixation of pelvic fractures, which has also been recently been licensed. He has published on solid state physics, display research and genome and biology and technology.